Rashmi Gopal-Srivastava currently serves as the director of the Extramural Research Program in the Office of Rare Diseases Research. She leads the Rare Diseases Clinical Research Network (RDCRN), a multidisciplinary national program. As the lead of RDCRN program, Gopal-Srivastava collaborates with 10 NIH Institutes to manage 22 consortia and a central Data Management Coordinating Center. The RDCRN has more than 200 participating sites in 17 countries and more than 100 Patient Advocacy Groups as research partners and conducts research on about 200 rare diseases.
Gopal-Srivastava has worked at NIH for the past 26 years with a diverse background in biochemistry, molecular biology and basic and translational research. She has experience in basic and translational science research, extramural science management, scientific review, managing public-private partnerships, and facilitating trans-NIH collaborations. Gopal-Srivastava joined NIH as a laboratory researcher in 1989 at the National Eye Institute, followed by an appointment as a health scientist administrator at National Cancer Institute (NCI). In 2003, she became a program director for a national translational research program, Specialized Program of Research Excellence, for breast cancer research in the Office of Director at NCI. She also managed a special program for the Avon Foundation–NCI partnership to support clinical research in breast cancer.
Gopal-Srivastava holds a Ph.D. in microbiology and immunology from the Medical College of Virginia at Virginia Commonwealth University. She is a past recipient of the Virginia Commonwealth fellowship and has received a research fellowship from the U.S. National Research Council of the National Academies of Science.
Gopal-Srivastava has been the recipient of the NIH Individual Merit Award numerous times. She also has received recognition from the U.S. Department of Health and Human Services for outstanding community services and NIH’s Asian Pacific Islander American Organization’s outstanding achievement award for excellence in science. She is an advocate for women in science and has recently been interviewed for the “Women of Color Scientists at NIH” and featured and showcased in “Women in Science at the National Institutes of Health 2007-2008.” Gopal-Srivastava has served as a keynote speaker at many national and international conferences.
Gopal-Srivastava’s professional interests at this time are focused on translational science and bringing better treatments faster to rare disease patients.